Literature DB >> 7627755

Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis.

J A Lomholt1, K Baggesen, N Ehlers.   

Abstract

Seventy-two penetrating primary keratoplasties for herpes simplex keratitis performed from 1970 to 1993 were reviewed. Postoperative follow-up periods ranged from 6 months to 16 years with 2 years median. Epithelial herpetic recurrence occurred in 25% of the transplants the first year and in 44% during the first 2 years. Primary allograft rejection was observed in 29% of the grafts the first year and in 46% during the first 2 years. Preoperative inflammation was a risk factor for preservation of a clear cornea (p < 0.10). The degree of corneal vascularization prior to operation did not influence the survival of the grafts. The overall one-year survival rate of a clear graft was 84% and the 2-year survival rate was 67%. Prophylactic antiviral treatment is discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7627755     DOI: 10.1111/j.1600-0420.1995.tb00008.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  12 in total

1.  Antiviral treatment following penetrating keratoplasty for herpetic keratitis.

Authors:  J F B Goodfellow; S Nabili; M N A Jones; D Q Nguyen; W J Armitage; S D Cook; D M Tole
Journal:  Eye (Lond)       Date:  2011-01-28       Impact factor: 3.775

2.  Persistent epithelial defects and ulcers in repeated corneal transplantation: incidence, causative agents, predisposing factors and treatment outcomes.

Authors:  Shimon Rumelt; Valery Bersudsky; Tami Blum-Hareuveni; Uri Rehany
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-24       Impact factor: 3.117

3.  Therapeutic effect of deep anterior lamellar keratoplasty for active or quiescent herpetic stromal keratitis.

Authors:  Junyi Wang; Ge Zhao; Lixin Xie; Min Chen; Jing Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-17       Impact factor: 3.117

4.  The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin.

Authors:  M Halberstadt; M Machens; K-A Gahlenbek; M Böhnke; J G Garweg
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

5.  Adverse effects of low-dose systemic cyclosporine therapy in high-risk penetrating keratoplasty.

Authors:  Jong Joo Lee; Mee Kum Kim; Won Ryang Wee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-21       Impact factor: 3.117

6.  Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells.

Authors:  Stéphanie Grosse; Nicolas Huot; Charlotte Mahiet; Sylvain Arnould; Sébastien Barradeau; Diane Le Clerre; Isabelle Chion-Sotinel; Cécile Jacqmarcq; Benoît Chapellier; Ayla Ergani; Carole Desseaux; Frédéric Cédrone; Emmanuel Conseiller; Frédéric Pâques; Marc Labetoulle; Julianne Smith
Journal:  Mol Ther       Date:  2011-01-11       Impact factor: 11.454

7.  HSV keratitis: histopathologic predictors of corneal allograft complications.

Authors:  Roni M Shtein; Denise D Garcia; David C Musch; Victor M Elner
Journal:  Trans Am Ophthalmol Soc       Date:  2008

8.  Herpes simplex virus keratitis: histopathologic inflammation and corneal allograft rejection.

Authors:  Roni M Shtein; Denise D Garcia; David C Musch; Victor M Elner
Journal:  Ophthalmology       Date:  2009-07       Impact factor: 12.079

9.  Long-term results of penetrating keratoplasty. A 10-year-plus retrospective study.

Authors:  Marc Muraine; Christian Sanchez; Laure Watt; Alain Retout; Gérard Brasseur
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-06-18       Impact factor: 3.117

10.  Herpes simplex virus keratitis: histopathologic neovascularization and corneal allograft failure.

Authors:  Denise D Garcia; Roni M Shtein; David C Musch; Victor M Elner
Journal:  Cornea       Date:  2009-10       Impact factor: 2.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.